Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
- C. Zocchi, E. Ongini, S. Dionisotti
- Biology, ChemistryThe Journal of pharmacology and experimental…
- 1 February 1996
TLDR
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
- J. Wallace, Stephanie D. Syer, E. Ongini
- MedicineGastroenterology
- 1 October 2011
TLDR
Interleukin‐10 modulates neuronal threshold of vulnerability to ischaemic damage
- M. Grilli, Ilaria Barbieri, E. Ongini
- BiologyThe European journal of neuroscience
- 1 July 2000
TLDR
Pharmacology of adenosine A2A receptors.
- E. Ongini, B. Fredholm
- BiologyTrends in pharmacological sciences
- 1 October 1996
The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice
- J. Chen, R. Moratalla, M. Schwarzschild
- Biology, Psychology
- 13 February 2001
TLDR
Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
- R. Strong, Richard A. Miller, D. Harrison
- BiologyAging cell
- 1 October 2008
TLDR
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
- A. Krauss, F. Impagnatiello, E. Ongini
- Medicine, BiologyExperimental eye research
- 1 September 2011
Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury.
- L. Briscini, L. Corradini, E. Ongini, R. Bertorelli
- BiologyEuropean journal of pharmacology
- 28 June 2002
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors
- E. Ongini, S. Dionisotti, S. Gessi, E. Irenius, B. Fredholm
- Biology, ChemistryNaunyn-Schmiedeberg's Archives of Pharmacology
- 1999
TLDR
Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
- B. Neustadt, Jinsong Hao, Kung-I Feng
- Chemistry, BiologyBioorganic & medicinal chemistry letters
- 1 March 2007
...
1
2
3
4
5
...